DCF — HILLCREST MEDICAL CENTER
Enterprise Value: $-383.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-383.8M
Enterprise Value
$-133.8M
PV of Cash Flows
$-250.0M
PV of Terminal Value
$-402.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $607.8M | $-17.2M | -3.0% | $-42.9M | $-39.0M |
| Year 2 | $626.0M | $-11.4M | -2.0% | $-37.9M | $-31.3M |
| Year 3 | $644.8M | $-5.3M | -1.0% | $-32.6M | $-24.5M |
| Year 4 | $664.2M | $-2.2M | -0.0% | $-30.3M | $-20.7M |
| Year 5 | $684.1M | $-0.5M | -0.0% | $-29.5M | $-18.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-383.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$590.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03324025153552735
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5